Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win

[Jaybee00]

Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win

An investigational drug for the autoimmune condition Sjögren's disease has scored a

www.fiercebiotech.com

 

[Jaybee00]

https://app.dealroom.co/news/note/amgen-s-dazodalibep-meets-primary-endpoint-in-phase-3-sj-gren-s-disease-trial